The COVID-19 pandemic threatens to reverse recent progress in reducing the global burden of tuberculosis. The global number of deaths for tuberculosis could increase by around 200.000–400.000 in 2020 alone, as result of essential tuberculosis services disruptions due to the reallocation of human, financial and other resources from tuberculosis to the COVID-19 response, as reported by WHO: https://bit.ly/35KyzD
Exemplary coordination of African researchers and scientists involved in the response to the pandemic to study treatments that prevent serious complications of COVID-19 https://bit.ly/37SvaCz
An international research team has begun patient enrollment in a clinical trial testing multiple investigational Ebola therapies in the Democratic Republic of the Congo (DRC). The randomized, controlled trial is
In Africa, pregnant women and young children are the most vulnerable to malaria. However, malaria control interventions and strategies have achivied important results in the last years. COVID-19 has now